NEW YORK UNIVERSITY
Total received in grants · trailing 12 months
$24M
$0for every U.S. household÷ 131M U.S. households
In perspective
0.0%of all $401.9B in tracked grants
7separate grants, trailing 12 months
NEW YORK UNIVERSITY has received $24M across 7 federal grants of $1M or more on record.
Data as of August 5, 2026. Source: USAspending.gov, prime contract awards $1M+. Federal spending data lags and has known gaps. This is not a real-time or complete record.
Grants by agency
Where this recipient’s grant dollars come from.
All grant awards
Swipe to see description and amount →
| Agency | Description | Amount |
|---|---|---|
| Department of Justice | THE PURPOSE OF THIS RESTORATIVE PRACTICES PILOT PROGRAM EVALUATION AWARD IS TO CONDUCT RESEARCH AND EVALUATION ON RESTORATIVE PRACTICES IN COLLABORATION WITH PILOT SITES AND TRAINING AND TECHNICAL ASSISTANCE (TTA) PROVIDERS. THIS PROJECT WILL BUILD EVIDENCE AND DATA FOR VICTIM-CENTERED, TRAUMA-INFORMED, AND CULTURALLY RESPONSIVE RESTORATIVE PRACTICES ADDRESSING DOMESTIC VIOLENCE, DATING VIOLENCE, SEXUAL ASSAULT, AND STALKING. NEW YORK UNIVERSITY WILL CONDUCT A MIXED-METHODS EVALUATION OF THE RESTORATIVE PRACTICES PILOT PROGRAM. THIS AWARD WILL SUPPORT RESEARCH PROJECTS THAT WILL GENERATE KNOWLEDGE THAT PRACTITIONERS, POLICYMAKERS, AND THE PUBLIC CAN USE TO MAKE DECISIONS ABOUT DEVELOPING, IMPLEMENTING, AND USING RESTORATIVE PRACTICES TO REDRESS THE HARM CAUSED BY DOMESTIC VIOLENCE, SEXUAL ASSAULT, DATING VIOLENCE, AND STALKING. NEW YORK UNIVERSITY WILL WORK IN CLOSE COLLABORATION WITH OVW STAFF, TTA PROVIDERS, EVALUATION LIAISONS, AND PILOT SITE PRACTITIONERS TO DEVELOP REASONABLE AND USEFUL EVALUATION MEASURES ACROSS AND WITHIN PILOT SITES. ADDITIONALLY, THE RESEARCH THAT OVW WILL FUND THROUGH THIS AWARD WILL MIRROR THE AIMS OF RESTORATIVE PRACTICES, USE MIXED-METHODS APPROACHES, AND BE ADAPTABLE AND COMMUNITY-SPECIFIC WITH STRONG RESEARCHER-PRACTITIONER-COMMUNITY PARTNERSHIPS. | $8,000,000 |
| Department of Health and Human Services | A MID-TO-LATE LIFE COURSE APPROACH TO INVESTIGATING THE IMPACT OF MENOPAUSE AND INTERVENTION ON BRAIN HEALTH - PROJECT SUMMARY COGNITIVE DECLINE AND NEURODEGENERATIVE DISORDERS, SUCH AS ALZHEIMER’S DISEASE (AD), DISPROPORTIONATELY AFFECT WOMEN, WHO FACE A 48% LIFETIME RISK OF DEVELOPING DEMENTIA—A NEARLY 40% HIGHER RISK COMPARED TO MEN. HEIGHTENED VULNERABILITY IN WOMEN IS ATTRIBUTED NOT ONLY TO GENETIC AND LIFESTYLE FACTORS BUT ALSO TO NEUROBIOLOGICAL SHIFTS DURING MIDLIFE TRANSITIONS, INCLUDING MENOPAUSE. EACH YEAR, 25 MILLION WOMEN ENTER THE MENOPAUSE TRANSITION, A CRITICAL PERIOD MARKED BY DECLINING ESTROGEN AND NEUROBIOLOGICAL CHANGES UNDERLYING HOT FLASHES, SLEEP DISRUPTION, MOOD DISTURBANCES, AND COGNITIVE SHIFTS. DESPITE THIS, SEX-SPECIFIC RISK FACTORS REMAIN POORLY UNDERSTOOD, AND CURRENT PREDICTION MODELS OF AD REMAIN PREDOMINANTLY SEX-NEUTRAL, FAILING TO ACCOUNT FOR REPRODUCTIVE HISTORY, HORMONAL CHANGES, AND ENDOCRINE INTERVENTIONS. ADDRESSING THESE GAPS IS ESSENTIAL FOR EARLY DETECTION, PRECISE RISK STRATIFICATION, AND TAILORED PREVENTION STRATEGIES FOR COGNITIVE DECLINE IN WOMEN. THIS PROJECT SEEKS TO UNCOVER THE NEUROBIOLOGICAL MECHANISMS OF MENOPAUSE, QUANTIFY THE IMPACT OF MENOPAUSAL HORMONE THERAPY (MHT) ON BRAIN HEALTH, AND IDENTIFY SEX-SPECIFIC MOLECULAR MEDIATORS OF ADVERSE BRAIN OUTCOMES. USING LONGITUDINAL NEUROIMAGING, PLASMA PROTEOMICS, AND CLINICAL ASSESSMENTS, WE WILL ELUCIDATE INDIVIDUAL RISK PROFILES AND DEFINE ACTIONABLE BIOMARKERS FOR PREVENTING LATE-LIFE BRAIN AGING. WE PROPOSE TO (A) MAP NEUROBIOLOGICAL CHANGES DURING MENOPAUSE TRANSITION AMONG A COHORT OF 120 PRE- AND PERIMENOPAUSAL WOMEN AGED 40–48, AN UNDERREPRESENTED AGE GROUP IN EXISTING STUDIES, USING STATE-OF-THE-ART NEUROIMAGING, HORMONE, AND SYMPTOM PROFILING. WE HYPOTHESIZE THAT PERIMENOPAUSAL ESTROGEN LOSS LEADS TO DYSCONNECTIVITY AND MYELIN DEGRADATION IN ESTROGEN-SENSITIVE BRAIN NETWORKS, CORRELATING WITH SYMPTOMS (AIM 1); (B) EVALUATE SEX-SPECIFIC RISK AND RESILIENCE FACTORS FOR ADVERSE BRAIN OUTCOMES USING FOUR DECADES OF DATA FROM THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY (N=2,649). BRAIN AGING OUTCOMES WILL BE EXAMINED BASED ON TIMING AND FORMULATION OF MHT, TESTING THE “CRITICAL WINDOW” HYPOTHESIS OF EARLY INITIATION BEING NEUROPROTECTIVE (AIM 2); AND (C) IDENTIFY PLASMA PROTEOMIC PROFILES MEDIATING SEX-SPECIFIC RISKS BY INTEGRATING LONGITUDINAL IMAGING AND PROTEOMICS. WE HYPOTHESIZE THAT PROTEINS IN INFLAMMATORY AND METABOLIC PATHWAYS LINK HORMONAL CHANGES TO ADVERSE BRAIN AGING (AIM 3). THIS RESEARCH WILL YIELD NEUROBIOLOGICAL MAPS OF MENOPAUSE, CHARACTERIZE MHT'S LONG-TERM IMPACT ON BRAIN HEALTH, AND IDENTIFY MOLECULAR MARKERS FOR PRECISION PREVENTION. FINDINGS WILL TRANSFORM CLINICAL CARE BY INFORMING PERSONALIZED GUIDELINES FOR MAINTAINING COGNITIVE HEALTH IN WOMEN ACROSS THEIR LIFESPAN. | $3,557,115 |
| Department of Health and Human Services | THE CURSE OF CHOICE IN ELDERS AND ITS REMEDIATION - ABSTRACT THIS RESEARCH INVESTIGATES THE WIDELY DISCUSSED CURSE OF CHOICE, THE OBSERVATION THAT AS THE NUMBER OF OPTIONS UNDER CONSIDERATION GROWS, DECISION QUALITY DECLINES. THIS EFFECT IS PARTICULARLY SEVERE IN OLDER ADULTS, ESPECIALLY THOSE WITH COGNITIVE DECLINE. PRELIMINARY DATA AND FIELD RESEARCH SHOW THAT TOO MANY CHOICES CAN INCREASE COSTS AND REDUCE QUALITY OF LIFE FOR SENIORS, WITH DECISION ACCURACY NEAR CHANCE FOR THOSE WITH COGNITIVE IMPAIRMENT WHEN THE NUMBER OF OPTIONS GROWS. THIS PROJECT RELIES ON A NEUROBIOLOGICAL MODEL FOR THIS PHENOMENON WHICH SUGGESTS THAT AGE-RELATED SENSITIVITY TO THE CURSE OF CHOICE IS DRIVEN BY DECLINES IN CORTICAL CAPACITY THAT LIMIT IN HOW THE BRAIN PROCESSES VALUE. HERE WE PROPOSE A STUDY TO 1) DEMONSTRATE A HYPERBOLIC RELATIONSHIP BETWEEN CHOICE EFFICIENCY AND CHOICE SET SIZE, 2) QUANTIFY HOW HYPERBOLIC COLLAPSE IN PERFORMANCE CHANGES WITH AGE-RELATED COGNITIVE IMPAIRMENT, 3) CHARACTERIZE THE RELATIONSHIP BETWEEN CHOICE SET SIZE, COGNITIVE CAPACITY, AND NEUROPSYCHOLOGICAL PHENOTYPE – IDENTIFYING PARTICULARLY SUSCEPTIBLE INDIVIDUALS, 4) IDENTIFY THE CORTICAL AREAS WHICH UNDERLY THIS LOSS OF FUNCTION, AND 5) TEST THEORY-DRIVEN STRATEGIES AIMED AT REDUCING OR ELIMINATING THE CURSE OF CHOICE. SUCCESSFUL COMPLETION OF THE STUDY SHOULD PROVIDE A NEW TOOL FOR USE IN GOVERNMENT AND PRIVATE WEBSITES OFFERING CHOICES TO ELDERS, AND SHOULD LAY THE FOUNDATIONS FOR FURTHER NEUROBIOLOGICAL STUDY OF THE PHENOMENA IN HUMANS AND ANIMAL MODELS. | $3,550,516 |
| Department of Health and Human Services | MEDICAID DELIVERY SYSTEM REFORM INCENTIVE PAYMENT (DSRIP) PROGRAMS: IMPACTS ON HEALTH CARE USE, COORDINATION, OUTCOMES, AND DISPARITIES AMONG PATIENTS WITH MENTAL ILLNESS - PROJECT SUMMARY AS THE LARGEST PAYER FOR MENTAL HEALTH CARE IN THE UNITED STATES, MEDICAID IS ADOPTING VALUE-BASED PAYMENT MODELS THAT LINK PROVIDER PAYMENTS TO QUALITY IN AN EFFORT TO IMPROVE OUTCOMES FOR HIGH-NEED POPULATIONS, INCLUDING INDIVIDUALS WITH A SERIOUS MENTAL ILLNESS (SMI). WITH OVER $55 BILLION IN JOINT STATE AND FEDERAL FUNDING, MEDICAID DELIVERY SYSTEM REFORM INCENTIVE PAYMENT (DSRIP) PROGRAMS REPRESENT THE MOST EXTENSIVE EFFORT TO IMPLEMENT VALUE-BASED PAYMENT IN MEDICAID TO DATE. THIRTEEN STATES HAVE IMPLEMENTED DSRIP PROGRAMS TO DATE. HOWEVER, NATIONAL EVIDENCE ON THE IMPACTS OF DSRIP PROGRAMS ON PATIENTS WITH SMI IS LACKING, BOTH OVERALL AND FOR SOCIODEMOGRAPHIC SUBGROUPS AT HIGH RISK OF EXPERIENCING POOR CARE AND OUTCOMES. FURTHERMORE, THERE IS LIMITED EVIDENCE ABOUT WHICH FEATURES OF DSRIP PROGRAMS YIELD POSITIVE BENEFITS—CRITICAL TO UNDERSTAND AS KEY PROGRAM ELEMENTS VARY ACROSS STATES. THE PROPOSED RESEARCH WILL ADDRESS THESE EVIDENCE GAPS BY EVALUATING THE IMPACTS OF DSRIP PROGRAMS AMONG COMMUNITY-DWELLING MEDICAID ENROLLEES WITH A DIAGNOSIS OF MAJOR DEPRESSION, BIPOLAR DISORDER, OR SCHIZOPHRENIA. USING NATIONAL MEDICAID CLAIMS AND ENCOUNTER DATA AND A DIFFERENCE-IN-DIFFERENCES DESIGN, THE PROJECT HAS THREE RESEARCH AIMS: 1) TO INVESTIGATE THE IMPACTS OF DSRIP PROGRAMS ON OUTPATIENT MENTAL HEALTH AND PRIMARY CARE USE AND HEALTH CARE QUALITY MEASURES INDICATIVE OF CARE COORDINATION AND HEALTH OUTCOMES FOR MEDICAID ENROLLEES WITH SMI; 2) EXAMINE HETEROGENEITY IN THE IMPACTS OF DSRIP PROGRAMS AMONG SUBGROUPS OF MEDICAID ENROLLEES WITH SMI ALONG THE DIMENSIONS OF RACE/ETHNICITY, HEALTH COMPLEXITY, DISABILITY STATUS, AND RURALITY; AND 3) IDENTIFY SPECIFIC DSRIP PROGRAMMATIC FEATURES THAT ARE ASSOCIATED WITH POSITIVE IMPACTS ON MEDICAID ENROLLEES WITH SMI, LEVERAGING VARIATION ACROSS STATES IN DSRIP PROGRAM DESIGN. BECAUSE DSRIP PROGRAMS ARE TIME-LIMITED BUT INTENDED TO INITIATE ENDURING DELIVERY SYSTEM IMPROVEMENTS, THIS RESEARCH WILL ALSO ASSESS LONGER-TERM IMPACTS AMONG MEDICAID-ENROLLED POPULATIONS WITH SMI. THIS STUDY ALIGNS WITH NIMH’S STRATEGIC PLAN TO COMPARE ALTERNATIVE FINANCING MODELS TO IMPROVE CARE FOR PATIENTS WITH SMI AND TO IDENTIFY APPROACHES TO REDUCE DOCUMENTED DISPARITIES IN CARE ACCESS, QUALITY, AND OUTCOMES FOR DISADVANTAGED SUBPOPULATIONS. FINDINGS WILL GENERATE EVIDENCE RELEVANT TO HEALTH CARE DECISION-MAKERS, INCLUDING HEALTH SYSTEMS, PAYERS, AND MEDICAID AGENCIES RESPONSIBLE FOR OVERSEEING CARE DELIVERY AND POPULATION HEALTH, AS THEY ASSESS MEDICAID PAYMENT AND DELIVERY SYSTEM MODELS FOR INDIVIDUALS WITH SMI. TO ENSURE THAT THE STUDY ADDRESSES OPERATIONALLY RELEVANT QUESTIONS, WE WILL ENGAGE A MULTI-SECTOR ADVISORY COUNCIL OF EXPERTS WITH EXPERIENCE IN MEDICAID MENTAL HEALTH CARE AND PAYMENT. THIS ENGAGEMENT WILL HELP PLACE FINDINGS IN CONTEXT FOR DECISION-MAKERS RESPONSIBLE FOR MONITORING CARE DELIVERY, QUALITY, AND POPULATION HEALTH IN MEDICAID. | $2,996,202 |
| Department of Energy | GENOME-SCALE MAPPING AND FUNCTIONAL CHARACTERIZATION OF CIS-REGULATORY NETWORKS IN CELLULAR REPROGRAMMING AND REGENERATION | $2,398,000 |
| Department of Energy | NEW AWARD DE-CR0000017 TO NEW YORK UNIVERSITY FOR PROJECT TITLED TRACKING REAL-TIME ANOMALIES IN POWER SYSTEMS | $1,939,416 |
| Department of Health and Human Services | BARBER-CLIP: EXPANDING VISION HEALTH SCREENING FOR DIABETIC RETINOPATHY THROUGH COMMUNITY ENGAGEMENT - PROJECT SUMMARY DIABETIC RETINOPATHY (DR) IS A LEADING CAUSE OF VISION IMPAIRMENT IN THE U.S., DISPROPORTIONATELY AFFECTING MEN IN UNDER-RESOURCED COMMUNITIES DUE TO ADVERSE SOCIAL DETERMINANTS OF HEALTH (SDOH), INCLUDING LIMITED ACCESS TO VISION CARE. EARLY DETECTION THROUGH TELE-SCREENING CAN PREVENT PROGRESSION TO BLINDNESS, BUT CURRENT HEALTHCARE SYSTEMS FAIL TO REACH AT-RISK POPULATIONS. TO ADDRESS THIS GAP, WE PROPOSE “BARBER-CLIP: EXPANDING VISION HEALTH SCREENING FOR DIABETIC RETINOPATHY THROUGH COMMUNITY ENGAGEMENT,” A COMMUNITY- ENGAGED, BARBERSHOP-BASED TELE-SCREENING MODEL. BUILDING ON OUR SUCCESSFUL HYPERTENSION-SCREENING PROGRAM (CLIP), BARBER-CLIP WILL TRAIN COMMUNITY HEALTH WORKERS (CHWS) TO SCREEN MEN FOR DR IN BARBERSHOPS AND REFER THEM TO CARE. WE HYPOTHESIZE THAT INTEGRATING DR TELE-SCREENING INTO THE COMMUNITY WILL IMPROVE EARLY DETECTION, INCREASE LINKAGE TO CARE, AND ENHANCE SUSTAINABILITY OF DR SCREENING EFFORTS. SPECIFIC AIMS AIM 1: IDENTIFY BARRIERS AND FACILITATORS OF BARBER-CLIP ADOPTION IN BARBERSHOPS USING THE CONSOLIDATED FRAMEWORK FOR IMPLEMENTATION RESEARCH (CFIR) TO DEVELOP A CONTEXT-SPECIFIC IMPLEMENTATION STRATEGY. AIM 2: CONDUCT A CLUSTER-RANDOMIZED CONTROLLED TRIAL (RCT) IN 22 BARBERSHOPS (N=11 INTERVENTION, N=11 CONTROL) TO EVALUATE THE EFFECT OF BARBERSHOP FACILITATION (BF) ON LINKAGE TO OPHTHALMOLOGIC CARE FOR DR (PRIMARY OUTCOME), ADOPTION OF BARBER-CLIP, AND DEVELOPMENT OF VISION THREATENING COMPLICATIONS (VTC) OF DR (SECONDARY OUTCOMES). AIM 3: ASSESS THE SUSTAINABILITY OF BARBER-CLIP AT 18 MONTHS AND EVALUATE ITS COST-EFFECTIVENESS USING THE REACH, EFFECTIVENESS, ADOPTION, IMPLEMENTATION AND MAINTENANCE (RE-AIM) FRAMEWORK. METHODS DATA WILL BE ANALYZED THROUGH A MIXED METHODS APPROACH TO ASSESS IMPLEMENTATION, EFFECTIVENESS, HEALTH OUTCOMES, AND ECONOMIC VIABILITY. IMPACT BARBER-CLIP LEVERAGES COMMUNITY-BASED RESOURCES TO MITIGATE SDOH AND IMPROVE ACCESS TO VISION CARE. THIS SCALABLE MODEL CAN TRANSFORM DR SCREENING EFFORTS NATIONWIDE. | $1,525,498 |